InvestorsObserver
×
News Home

Pfizer Inc. (PFE) is up 11.71% in a Week, Should You Hold?

Monday, June 27, 2022 12:06 PM | InvestorsObserver Analysts

Mentioned in this article

Pfizer Inc. (PFE) is up 11.71% in a Week, Should You Hold?

A rating of 88 puts Pfizer Inc. (PFE) near the top of the Drug Manufacturers - General industry according to InvestorsObserver. Pfizer Inc.'s score of 88 means it scores higher than 88% of stocks in the industry. Pfizer Inc. also received an overall rating of 77, putting it above 77% of all stocks. Drug Manufacturers - General is ranked 8 out of the 148 industries.

Overall Score - 77
PFE has an Overall Score of 77. Find out what this means to you and get the rest of the rankings on PFE!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 77 would rank higher than 77 percent of all stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Pfizer Inc. Stock Today?

Pfizer Inc. (PFE) stock is trading at $51.98 as of 11:58 AM on Monday, Jun 27, a gain of $0.39, or 0.76% from the previous closing price of $51.59. The stock has traded between $51.26 and $52.23 so far today. Volume today is below average. So far 6,298,885 shares have traded compared to average volume of 24,119,842 shares. Click Here to get the full Stock Report for Pfizer Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App